Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) shares up in the sky after this update

Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) stock soared 17.36% to $1.42 in the pre-market trading session following an announcement by a biopharmaceutical corporation focusing on advancing immunology-based treatments for common inflammatory disorders that two collaboration have been reached to explore potential therapeutic applications for its immunomodulatory drug, Ampion. The Organization has entered into a cooperative […]